Do early prednisolone and other immunosuppressant therapies prevent generalization in ocular myasthenia gravis in Western populations: a systematic review and meta-analysis

Do early prednisolone and other immunosuppressant therapies prevent generalization in ocular myasthenia gravis in Western populations: a systematic review and meta-analysis

Background: The majority of ocular myasthenia gravis (OMG) patients will progress to generalized myasthenia gravis (GMG), usually within 2 years of disease onset. The aim of this meta-analysis was to evaluate the effect of early prednisolone and other immunosuppressants therapy on the generalization...

Full description

Bibliographic Details
Main Authors: Mingxia Li, Fangfang Ge, Rongjing Guo, Zhe Ruan, Yanwu Gao, Chunxiao niu, Hong Lin, Zhengwei Zhao, Yongan Zhou, Zhuyi Li, Ting Chang
Format: Article
Language:English
Published: SAGE Publishing 2019-09-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/1756286419876521

Internet

https://doi.org/10.1177/1756286419876521

Similar Items